Speakers

Amanda Bruegl, MD, MS is Assistant Professor of Obstetrics and Gynecology, School of Medicine at Oregon Health & Science University. She earned her MD from University of Washington School of Medicine in 2007, and an MS from University of Texas Graduate School of Biomedical Sciences in 2013.

Patty Cason, MS, FNP-BC is a family nurse practitioner and educator with a specialty in sexual and reproductive health. She has practiced for 36 years in a wide variety of clinical settings. Patty developed the “PATH” framework for patient-centered reproductive counseling and she heads up the Sexual Agency Project. Patty is a senior author and editor of the recently published 21^st edition of Contraceptive Technology. Her other publications include research and opinion pieces in peer reviewed journals, nationally utilized on-line learning courses, instructional videos, textbook chapters, clinical protocols, job aids and manuals on provision of sexual and reproductive health services and integration of sexual and reproductive health services into primary care settings.

David P. Chelmow, MD is the Leo J Dunn Professor and Chair of Obstetrics and Gynecology at Virginia Commonwealth University. He complete his MD at Yale University Medical School and Residency at UCSF. Dr. Chelmow is the 2021-2022 ASCCP President.

Lawrence Cheskin, MD has been dedicated to research, education, and program building in the service of combatting obesity, through both treatment and prevention. Treatment is modeled by the Johns Hopkins Weight Management Center, founded in 1990.  He is now Professor and Chair of Nutrition and Food Studies at George Mason University, and Adjunct Professor of Medicine at Johns Hopkins.

Megan Clarke, PhD, MHS earned an M.H.S. in biochemistry and molecular biology in 2010 and a Ph.D. in epidemiology in 2016, both from the Johns Hopkins Bloomberg School of Public Health. She completed postbaccalaureate and postdoctoral (as a Cancer Prevention fellow) fellowships in the Clinical Genetics Branch. She was promoted to research fellow in 2019 and was appointed as an Earl Stadtman Tenure-Track Investigator in 2020. Dr. Clarke has received numerous awards for her work, including an Intramural Research Award, NCI Director’s Intramural Innovation Award, and the William G. Coleman Jr. Ph.D., Minority Health and Health Disparities Research Innovation Award.  

Craig R. Cohen, MD, MPH, is a Professor in the UCSF Department of Obstetrics, Gynecology and Reproductive Sciences, an Attending Physician at San Francisco General Hospital and co-Director of the University of California Global Health Institute (UCGHI: www.ucghi.universityofcalifornia.edu). He conducts clinical and implementation research in two major areas: HIV and sexually transmitted infection prevention and HIV/AIDS care and support in developing countries with a particular focus on the development of live biotherapeutic products to prevent bacterial vaginosis and HIV acquisition in women.

Christine Conageski, MD is an Associate Professor in the Division of General Obstetrics and Gynecology at the University Colorado School of Medicine.  She completed her medical school training at the University of Cincinnati and her Gynecology/Obstetrics residency at the University of Colorado. She also completed a Masters in Clinical Science through the Colorado Clinical and Translational Sciences Institute. 

Dr. Conageski is the Director of the University of Colorado Colposcopy Clinic. She practices general obstetrics and gynecology, and her clinical and research interests focus on HPV-associated diseases of the lower genital tract, screening disparities and infectious diseases of the lower genital tract. She has served as the course director for ASCCP Comprehensive Colposcopy course, as a member of the ASCCP Board of Directors, and is a member or chair of several ASCCP committees.

Teresa Darragh, MD is Professor of Pathology at UCSF’s Department of Pathology with a joint appointment in Department of Obstetrics, Gynecology and Reproductive Sciences. Her primary clinical and research interests are focused on HPV-associated anogenital tract disease.  She is board certified in Anatomic Pathology with an added qualification in Cytopathology. For 25 years, she was an attending colposcopist in UCSF’s Dysplasia Clinic.

Dr. Darragh is Past President of ASCCP.  She is former chair of the ASCCP’s Pathology Committee and a former member of the College of American Pathologists (CAP) Cytopathology Resource Committee.  She co-chaired, along with Dr. David Wilbur of Harvard University Medical School, Massachusetts General Hospital, the LAST Project on standardizing terminology for HPV-associated squamous lesions of the lower anogenital tract, jointly sponsored by CAP and ASCCP. The LAST Project’s recommendations for squamous intraepithelial lesions have been adopted by the WHO for the cervix, vagina, and vulva. She has also contributed to the Bethesda System Atlas on Gynecologic Cytology.

Dr. Darragh is actively involved with multiple clinical research projects investigating HPV-associated anogenital tract disease in men and women. She is a member of the Central Coordinating Group for the International Agency for Research on Cancer (IARC)’s ESTAMPA project, a multi-center study in Latin America using primary HPV testing for cervical cancer screening. She is also the central pathology reviewer for the NCI’s ongoing studies in Guanacaste, Costa Rica and for ANCHOR, the anal cancer study.

Sarah E. Dilley, MD received a bachelor of arts degree from Emory University. She received a master of public health degree from Harvard University and a medical degree from Indiana University School of Medicine. She completed an ob/gyn residency at Oregon Health and Science University and a gynecologic oncology fellowship at University of Alabama at Birmingham.

Didem Egemen, PhD is a statistician at the National Cancer Institute (NCI) Division of Cancer Epidemiology and Genetics (DCEG). She works primarily on cervical cancer research and previously estimated the risks underlying new risk-based management guidelines. These guidelines represent the consensus of 19 organizations, including the ASCCP, ACS, CDC, and NCI. Dr. Egemen has continued working on management guidelines as part of the Enduring Guidelines project which aims to incorporate new technologies, such as dual stain and extended genotyping, into the risk-based framework. She also serves as the lead statistician for multinational project on developing an automated visual evaluation tool for cervical cancer screening that can work via smart phone. This AI-based tool could potentially be a game changer for cervical cancer screening in low- and middle-income countries, providing highly accurate, reliable, low-cost and point-of-care diagnostics for cervical precancer. Her other research interests include risk estimation, the use of risk to inform cancer screening and prevention strategies, and the development of AI-based imaging tools for screening. Dr. Egemen completed her Ph.D. in statistics from the George Washington University. She also holds B.S. and M.S. degrees in statistics from the Middle East Technical University in Ankara, Turkey.

Mark H. Einstein, MD, MS is Professor and Chair of Obstetrics, Gynecology and Women's Health at Rutgers New Jersey Medical School. Dr. Einstein is a Gynecologic Oncologist who is an expert at identification and treatment of gynecologic malignancies. His primary research interests focus on the pathogenesis, therapy, and prevention of lower anogenital tract and gynecologic cancers. He leads numerous clinical efforts identifying unique targets and biomarkers for clinical risk of malignant transformation. He is also testing many novel drugs for cancer treatment. He has been an active leader for management guidelines and translating clinical trial and translational data for such organizations as the World Health Organization (WHO), American Cancer Society (ACS), Society of Gynecologic Oncology (SGO), American College of Obstetrics and Gynecology (ACOG), and Society of Lower Genital Tract Disease (ASCCP). He serves on the Boards for SGO and the ASCCP. He has served on numerous committees and leadership for the National Cancer Institute (NCI)-funded NRG Oncology group and AIDS Malignancy Consortium (AMC). Currently, he serves as a principal investigator on many multi-institutional clinical trials for gynecologic cancers in the US and Internationally. He has been funded for his research efforts by a number of organizations including the NCI, ACS, Foundation for Women's Cancers, and
others.  

John Farley, MD is a 1986 graduate of the United States Military Academy, and a 1990 graduate of USUHS. He completed a residency in Obstetrics and Gynecology at Walter Reed Army Medical Center, followed by a fellowship in Gynecologic Oncology. Dr. Farley started his medical career as an active duty soldier in the US Army and has been stationed in Fort Benning Georgia, Portsmouth Virginia, and Honolulu, Hawaii. He was deployed in support of Operation Enduring Freedom in Bagram Afghanistan from April 2004 until June 2005 where he was awarded the Bronze Star for his support of the female soldiers in theater and support of humanitarian care to the native Afghan population.  Dr. Farley is an active member of NRG Oncology and has executed multi-institutional clinical trials. He has authored over eighty peer reviewed manuscripts, and invited book chapters. He has also been an active participant in the Society of Gynecologic Oncology (SGO) and held several committee appointments to include: Diversity and Inclusion Committee, Legislative & Regulatory Affairs Task Force, and Membership Committee. He has received various awards to include: Order of Military Medical Merit, APGO Excellence in Teaching Award, induction in Alpha Omega Alpha Medical Honor Society, and SGO Ambassador Award. Currently, Dr. Farley is the Professor of Obstetrics and Gynecology at Creighton University School of Medicine at St. Joseph's Hospital and Medical Center and serves as a Chief Division of Gynecologic Oncology and staff physician in the Departments of Obstetrics and Gynecology at University of Arizona Cancer Center at St Joseph’s Hospital and Medical Center.

Sarah Feldman, MD, MPH is the Director Ambulatory Gynecologic Oncology and Center for Pre-invasive Disease of the Lower Genital Tract and Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Brigham and Women’s Hospital.

Lisa Flowers, MD, MPH, is Professor in the Department of Gynecology & Obstetrics at Emory University School of Medicine. Dr. Flowers joined the Emory faculty in 1999. She is active on many national and state committees aimed at improving the quality and delivery of care and service to patients with cervical and breast disease, including work with the American Society for Colposcopy and Cervical Pathology, American College of Obstetrics and Gynecology, and American Cancer Society. Dr. Flowers is a member of Alpha Omega Alpha Honor Society, the American College of Obstetricians and Gynecologists, International Anal Neoplasia Society and is a member and on the Board of Directors of American Society for Colposcopy and Cervical Pathology. She is also on the DHHS/CDC Breast and Cervical Cancer Early Detection and Control Advisory Committee. Dr. Lisa Flowers received her medical degree from Case Western Reserve University School of Medicine, in Cleveland, Ohio. She completed her residency in obstetrics and gynecology at Magee-Women’s Hospital of the University of Pittsburgh Medical Center in 1996. Dr. Flowers is board certified in obstetrics and gynecology. Dr. Flowers’ research interests include treatment for HPV-related disease, HPV and cervical cancer educational programs, and ovarian cancer surveillance for women with breast cancer susceptibility genes. She is currently the Emory Principal Investigator for several clinical trials entailing biomarker discovery, risk assessment and treatment for anal neoplasia. Dr. Flowers is slated to be the ASCCP President 2022-2023.

Francisco Garcia, MD, MPH is the Deputy County Administrator & Chief Medical Officer, Health and Community Services for Pima County in Arizona. He is currently a member of the ASCCP Executive Committee.

Michael Gold, MD is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at the University of Oklahoma School of Community Medicine. Dr. Gold specializes in gynecologic oncology and pelvic surgery.

Dr. Gold received his medical degree from Jefferson Medical College in Philadelphia, PA. He completed his residency in gynecology and obstetrics at Thomas Jefferson University Hospital, also in Philadelphia. After residency, Dr. Gold completed his three-year fellowship in gynecologic oncology at the University of Oklahoma Health Sciences Center in Oklahoma City, where he remained on the faculty for nine years. He then moved to Vanderbilt University Medical Center, where he was the Director of the Division of Gynecologic Oncology.

Dr. Gold’s clinical interests include the prevention and treatment of cervical cancer and pre-cancer (dysplasia) of the cervix, vagina, and vulva. He is active in clinical research focusing on gynecologic cancers in general and the imaging of cervical and uterine cancer, in particular.

Dr. Gold is board certified by the American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology. Dr. Gold is a Fellow of the American College of Obstetricians and Gynecologists and the American College of Surgeons. He is an active member of the Gynecologic Oncology Group, the Society of Gynecologic Oncologists, the American Society of Colposcopy and Cervical Pathology, and the American College of Radiology Imaging Network. Dr. Gold is an ASCCP past president.

Hope K. Haefner, MD, is the Harold A. Furlong Professor of Women’s Health in the Department of Obstetrics and Gynecology at the University of Michigan Hospitals in Ann Arbor, Michigan where she received her medical degree. Dr. Haefner completed her obstetrics and gynecology residency at the University of Michigan Medical Center in 1990. She completed a fellowship in gynecologic pathology in 1993. Dr. Haefner is board certified in obstetrics and gynecology.

She opened the University of Michigan Center for Vulvar Diseases in 1993.  It is one of a few clinics in the United States that specializes in treating these conditions. She has a national and international reputation in this field.  She is a specialist in vulvoscopy. She has a particular interest in high grade squamous intraepithelial lesions of the vulva, lichen sclerosus, lichen planus and hidradenitis suppurativa (including skin grafts and flaps for patients with Stage 3 hidradenitis suppurativa).  She is the primary author of the Vulvodynia Guideline, published in 2005.  Dr. Haefner is active in vulvovaginal disease research. She was a co-investigator on a R01 with Dr. Barbara Reed, the Longitudinal Population-Based Study of Vulvodynia. 

Dr. Haefner is Past President of ASCCP.

Debra Heller, MD received her medical training at New York Medical College and completed her residency in Obstetrics and Gynecology at Beth Israel Medical Center in New York . After several years in practice, her education continued at Mount Sinai School of Medicine where she completed both a residency in Anatomic Pathology, and fellowships in Pediatric Pathology and Gynecological Pathology. She is a diplomate in Pediatric Pathology, Anatomic Pathology, and Obstetrics & Gynecology. Dr. Heller is Professor with tenure of Pathology, Immunology, & Laboratory Medicine, with joint appointments in the Department of Obstetrics, Gynecology and Women’s Health as well as the Department of Pediatrics at Rutgers-NJ Medical School. Dr. Heller is the author of almost 300 published articles and numerous books and book chapters on issues relating to gynecology, gynecologic oncology as well as poor pregnancy outcomes. She serves as an Associate Editor for the Journal of Lower Genital Tract Disease, and has been on several ASCCP committees.

Warner K. Huh, MD is Professor, Vice Chair of Gynecology, Director of the Division  of Gynecologic Oncology, and the Margaret Cameron Spain Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB), Professor in the Department of Surgery, and Professor in the
Department of Epidemiology in the UAB School of Public Health, and Senior Medical Officer and Senior Scientist in the UAB Comprehensive Cancer Center. His research interests include screening and prevention of HPV related diseases as well as novel immunotherapeutic approaches for pre-invasive disease of the cervix as well as cervical cancer. He has authored or co-authored over 225 articles in journals including The New England Journal of Medicine, Lancet, Lancet Oncology, Journal of the National Cancer Institute Cancer, Clinical Cancer Research, Gynecologic Oncology, Obstetrics & Gynecology, and the American Journal of Obstetrics & Gynecology (h-index: 47). He serves as co-PI of the Johns Hopkins-UAB-University of Colorado Cervical Cancer Specialized Programs of Research Excellence 
(SPORE) program (2P50CA098252-06A1). Dr. Huh serves on the editorial boards of Gynecologic Oncology and The Journal of Lower Genital Tract Disease. He 
is a Past President of ASCCP. Dr. Huh has also served on the Board of Directors for the Society of Gynecologic Oncology (SGO).

Dominique Jodry, MD is an obstetrician-gynecologist in Atlanta, Georgia and is affiliated with UCHealth University of Colorado Hospital. She received her medical degree from Tulane University School of Medicine and has been in practice for less than 3 years.

Michelle J. Khan, MD, MPH is a Physician with The Permanente Medical Group in Northern California.  She completed her medical school training at Rutgers - Robert Wood Johnson Medical School, Maters in Public Health at Rutgers – School of Public Health, residency in Gynecology/Obstetrics at the Johns Hopkins Hospital, and fellowship in Reproductive Infectious Diseases at the University of California San Francisco.  Her clinical practices are located at Kaiser Permanente San Leandro Medical Center and Kaiser Permanente San Francisco Medical Center.  She practices general obstetrics and gynecology, with a focus on HPV-associated diseases of the lower anogenital tract.  She is active in research related to HPV and other reproductive tract infections and has published in high-impact journals including Journal of the National Cancer Institute, Obstetrics and Gynecology, and Annals of Internal Medicine.  She is an enthusiastic educator and has served as faculty for several ASCCP Comprehensive Colposcopy courses, ASCCP Annual meetings, and International Anal Neoplasia Society High-Resolution Anoscopy courses including a recent course in Cuba.  Dr. Khan was a Member-at-Large on the ASCCP Board of Directors and has been involved in several ASCCP committees including the Steering Committee for the Risk-Based Management Guidelines.  For the Colposcopy Standards, she served as the Co-Chair for Working Group 1 – Terminology. 

Lindsay Kuroki, MD, MSCI is a Assistant Professor of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine. She received her MD from Brown University in 2009. She is currently on the Board of Directors for ASCCP.

Shuk On Annie Leung, MD practices as a Gynecologic Oncologist at the McGill University Health Center in Montreal, Canada. She is also an Assistant Professor at McGill University and a Clinician-Scientist at the McGill University Health Center Research Institute. 

Kimberly Levinson, MD, MPH, is an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Dr. Levinson received her undergraduate degree from Tufts University. She earned her M.D. from the Johns Hopkins University School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her medical residency at the Johns Hopkins University School of Medicine and performed a clinical fellowship in gynecologic oncology at Cleveland Clinic. Dr. Levinson has also completed international research at Preventive Oncology International in Peru and the School for International Training in Chile. Dr. Levinson joined the Johns Hopkins faculty in 2014.

Eileen Duffey-Lind, RN is a Pediatric Nurse Practitioner, Pediatric Oncology, at the Dana-Farber Cancer Institute. She is the founder of the patient advocacy group Team Maureen.

E.J. Mayeaux, Jr., MD is a Professor of Family Medicine, Associate Vice Chancellor for Clinical Affairs, and Senior Associate Dean for Population Health and Primary Care at LSU Health Sciences Center in Shreveport, Louisiana, USA.  He is also the Ochsner-LSUHS Primary Care Service Line Lead. 

A USA Louisiana native, Dr. Mayeaux obtained his bachelor’s degree in Microbiology from Louisiana State University in Baton Rouge and a medical degree from Louisiana State Medical Center in Shreveport. He is board certified in Family Medicine and Preventive Medicine–Clinical Informatics. Dr. Mayeaux worked for 23+ years at Louisiana State University Health Sciences in Shreveport. He served as vice-chairman and residency director of the department of family medicine. In addition, he was appointed Professor of Family Medicine and Professor of Obstetrics and Gynecology.

In 2013 he was appointed as the Professor and Chairman of the Department of Family and Preventive Medicine at the University of South Carolina (USC) School of Medicine in Columbia, SC.  He later became Chairman of the Palmetto Health USC Medical Group Department of Family Medicine. He was recruited back home to LSUHS in 2020 to develop population health and value based care. 

Dr. Mayeaux has taught for the American Academy of family physicians 1992. He has made regular presentations at Family Medicine Experience, Infant Child and Adolescent Medicine, Skin Diseases, and Adult Medicine courses. He is also been an invited speaker on women’s health and primary care topics throughout the world. 

Dr. Mayeaux has been an active member of the American Society for Colposcopy and Cervical Pathology (ASCCP) and the International Federation for Colposcopy and Pathology of the Cervix (IFCPC) since 1996.  He is currently on the executive board of IFCPC and was ASCCP President in 2014. He serves on a number of committees including the International Education & Humanitarian Outreach Committee. He is the lead editor of Modern Colposcopy, 3rd edition, the flagship publication on colposcopy from the ASCCP.  Modern colposcopy has recently been translated into Chinese, among other languages, and is used worldwide. 

Dr. Mayeaux is a well-respected educator, skilled clinician and acclaimed author. He has published and edited 9 books including the Color Atlas of Family Medicine and the Essential Guide to Primary Care Procedures, both of which are available in multiple languages. He regularly lectures all over the world on a variety of women's health in primary care topics.

Dr. Mayeaux’s clinical expertise includes women’s health topics such as cervical disease, HPV disease, HPV vaccination, skin diseases and patient literacy as it relates to clinical medicine. He also speaks regularly on leadership topics, skin diseases and skin surgery, medical burnout, joy in medicine, and other topics. He has dedicated the majority of his professional life to the study and practice of women's health.

Anna-Barbara Moscicki, MD is Professor of Pediatrics at UCLA, Division Chief of Adolescent and Young Adult Medicine, and Associate Vice Chair of Clinical Research, Department of Pediatric. Dr. Moscicki is Past President for the ASCCP. Dr. Moscicki’s career has focused on adolescent gynecology and sexually transmitted infection research with a specific focus in Human Papillomavirus, HIV infection and mucosal immunology. Dr. Moscicki has been the principle investigator of a natural history study of HPV in adolescents and young women since 1990, one of the longest running HPV cohorts. Her work was highly influential in forming the new cervical cancer screening guidelines and triage of abnormal cytology in young women. Her recent work focuses on mucosal immunology and the vaginal microbiota. She has been involved in numerous clinical trials including vaginal microbiocides and an ongoing one dose HPV vaccine trial. She is also involved in health outcomes in perinatally HIV infected children including HPV vaccine efficacy, sexual risk behaviors, substance use, oral health, microbiomes, and HPV infections and has worked with numerous Networks on HIV disease in children and adolescents including Adolescent Medicine HIV/AIDS Research Network, Adolescent Therapeutic Network, IMPAACT and PHACS. She has over 150 publications and she serves on numerous national and international committees, including the W.H.O., N.I.H., ASCCP, and the American Cancer Society.

Akiva P. Novetsky, MD, MS is an Associate Professor in the Department of Obstetrics, Gynecology & Women’s Health at the Rutgers New Jersey Medical School.  He is also the Chief Quality officer for the Rutgers Cancer Center of New Jersey. 

Dr. Novetsky obtained his bachelor’s degree in Biology from Yeshiva University and a medical degree from Albert Einstein College of Medicine. He is board certified in Obstetrics and Gynecology and Gynecologic Oncology.

Dr. Novetsky is an active member of the the American Society for Colposcopy and Cervical Pathology (ASCCP) and currently serves as the Chair of the Assessment Committee and is a co-Chair of the 2020 ASCCP annual meeting.  He is an associate editor for the Journal of Lower Genital Tract Disease and serves as a reviewer for multiple other journals.  Dr. Novetsky served on the working groups that developed the Colposcopy Standards guidelines, published in 2017 and is currently serving on the working group and steering committee for the development of new management guidelines. 

Dr. Novetsky’s clinical expertise includes women’s cancers including: cervical, uterine, ovarian, vulvar and vaginal cancers as well as the pre-malignant conditions associated with these diseases.

Joel M. Palefsky, MD is an expert in infectious diseases and in cancers associated with these diseases. His expertise includes treating anal dysplasia, a precancerous condition that may lead to anal cancer and that is caused by the human papillomavirus (HPV).

Palefsky studies the biology of HPV and the Epstein-Barr virus, and is active in the development of new treatments.

Palefsky earned his medical degree at McGill University and completed a fellowship in infectious disease at Stanford University.

Palefsky is founder and president of the International Anal Neoplasia Society and president-elect of the International Papillomavirus Society.

Rebecca L. Pearl, PhD is an Assistant Professor in the Department of Clinical and Health Psychology and in Social and Behavioral Sciences at the University of Florida College of Public Health and Health Professions. Dr. Pearl’s research investigates health-and appearance-based stigma, with a primary focus on understanding and combatting weight stigma. Her work explores biosocial mechanisms by which stigma affects health, structural-level processes that may perpetuate or prevent stigma, and clinical interventions to reduce the internalization of stigma. Dr. Pearl received her Ph.D. in clinical psychology from Yale University and completed her postdoctoral fellowship at the University of Pennsylvania Perelman School of Medicine.

Rebecca B. Perkins, MD, MSc is an Associate Professor of Obstetrics and Gynecology at Boston University School of Medicine, and a practicing gynecologist at Boston Medical Center.  Her career is dedicated to reducing health disparities in cervical cancer. Her current research focuses on improving utilization of HPV vaccination and cervical cancer screening guidelines.  Dr. Perkins is currently working on national projects related to HPV vaccination and cervical cancer prevention with the American Cancer Society, American Academy of Pediatrics, American College of Obstetricians and Gynecologists. For ASCCP, she has been a working group member for the Colposcopy Standards project, Co-Chair and Chair of the Practice Committee, and currently serves as Co-Chair of the 2019 ASCCP Risk-Based Management Consensus Guidelines. 

Megha Ramaswamy, PhD, MPH serves as Professor of Population Health at University of Kansas School of Medicine and in the University of Kansas Cancer Center, an NCI-designated cancer center. For the last decade, her work on cancer prevention among marginalized populations has been continuously supported by NIH/NCI. She developed behavioral and systems-level interventions that addresses the intersection of sexual health and cancer prevention. She takes community health problems, works with stakeholders who are experts of their own lives, and comes up with plans for how best to implement solutions at individual, practice, and policy levels.

Cynthia A Rasmussen MD, FACOG and obstetrician gynecologist, is a Director Emerita, Vulvovaginal Services at Atrius Health in Burlington MA. She is a Clinical Instructor, Harvard Medical School, Tufts Medical School, Dartmouth Medical School and a NAMS Certified Menopause Practitioner.

Debbie Saslow, PhD, is the Managing Director of HPV & GYN Cancers at the American Cancer Society where she has worked since 1997.  Dr. Saslow serves as the ACS lead for HPV-related cancers and directs their HPV vaccination nationwide priority program of work, provides strategic direction and leads staff teams working on the implementation of HPV related activities, and provides evidenced-based guidance to the organization. She is responsible for developing and updating ACS guidelines, including guidelines for cervical cancer screening and for HPV vaccination.  Dr. Saslow is also the Principal Investigator on two cooperative agreements to increase HPV vaccination, and serves as the Vice-Chair of the National HPV Vaccination Roundtable.

Dr. Saslow received her undergraduate degree in biology with honors from Brown University, her PhD in human and molecular genetics from Yale University, and completed a post-doctoral fellowship at the National Cancer Institutes’ Laboratory of Pathology in Women’s Cancers.

Natalie Saunders, MD is a Clinical Assistant Professor in Obstetrics and Gynecology at the University of Michigan Health System.  She has an expertise in lower genital tract diseases including colposcopy and vulvar diseases. Dr. Saunders is faculty in the Center for Vulvar Diseases at the University of Michigan.

Isabel C. Scarinci, PhD, MPH is behavioral scientist with expertise and experience in the development, implementation, and evaluation of cervical cancer prevention and control interventions in low-resource settings (including rural areas in the U.S. and low- and middle-income countries).  She also leads a number of capacity building programs in cancer disparities targeting undergraduate and graduate students, post-doctoral fellows, and junior faculty in collaboration with other universities in the U.S. and abroad. In addition to her research and education efforts, she is very committed to community service and scalability of evidence-based approaches toward the elimination of cervical cancer as a public health problem. One example of her community work in Alabama is a 15-year program to promote breast and cervical cancer screening among Latina immigrants that rely 100% on the work of committed volunteers – Sowing the Seeds of Health. She was recently chosen on one of the six champions of health worldwide by Rotary International for her work in cervical cancer prevention and control in Sri Lanka and other low- and middle-income countries.

Mark Schiffman, MD, MPH received an M.D. from the University of Pennsylvania and an M.P.H. in epidemiology from The Johns Hopkins School of Hygiene and Public Health. He joined the NCI as a Staff Fellow in 1983 and, in 1996, was appointed Chief of the Interdisciplinary Studies Section in the Environmental Epidemiology Branch (which later became the HPV Research Group in the Hormonal and Reproductive Epidemiology Branch). He  joined the Clinical Genetics Branch in October 2009 to study intensively why HPV is such a powerful carcinogenic exposure, akin to an acquired genetic trait with high penetrance for a cancer phenotype. 

Peter F. Schnatz, DO is the Associate Chairman and Residency Program Director in the Department of ObGyn at The Reading Hospital in Pennsylvania where he also served as interim Chair from 2014 to 2015. Dr. Schnatz was trained at the University of Connecticut as an ObGyn and Internist, currently on the Drexel University faculty. Dr. Schnatz is a Past President of the North American Menopause Society (NAMS) and the Philadelphia ObGyn Society. He is on the Board of Advisors to The Advancing Health After Hysterectomy Foundation, Inc (AHAH). Dr. Schnatz is on the Editorial Boards of the Journal Menopause and the Journal of Lower Genital Tract Disease. Dr. Schnatz is a regular faculty member for ASCCP courses, is a past Chair of the ASCCP education committee, and is on the ASCCP Board of Directors. He is a past CREOG Region II Program Director’s Representative to the CREOG Council as well as a number of ACOG committees, is an ABOG oral board examiner, a reviewer for multiple journals, is an editorial Board member in collaboration with SASGOG and the Foundation for Excellence in Women's Health for the Pearls of Excellence, and Vice Chair; Pearls-Publications Committee. Dr. Schnatz is the Founder, Chairman of the Board, and CEO of FaithCare, Incorporated, an organization involved in humanitarian aid both locally and internationally. He has done international medical trips to serve the neediest of the needy in places like Africa, Haiti, and Siberia for over 20 years on a minimum of 1 week per year and often longer. He regularly sees women in need in the local cities where he lives and has founded 2 free health clinics, one in Hartford CT and one in Reading PA. Dr. Schnatz is a NAMS Certified Menopause Practitioner and is actively involved as both a clinician and a researcher. Dr. Schnatz’s research interests include menopause (hormonal therapy, vitamin D, and coronary artery disease), cervical dysplasia, Atypical Glandular Cells, and medical education.  Dr. Schnatz has given numerous Regional, National, and International lectures. He has numerous publications and many award-winning papers and/or presentations. He has more than 200 publications, with at least 125 of those as peer reviewed medical articles. Dr Schnatz graduated from the Rowan University School of Osteopathic Medicine and completed his Internal Medicine and ObGyn residencies at The University of Connecticut (UConn), in Farmington, Connecticut. Dr. Schnatz, his wife Melanie, and his 4 beautiful Children, Rebekah, Abigail, Sarah, and David, live in Reading PA.

Melissa A. Simon, MD, MPH  is the George H. Gardner Professor of Clinical Gynecology, Vice Chair of Research in the Department of Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine. She is also the Founder and Director of the Center for Health Equity Transformation and the Chicago Cancer Health Equity Collaborative and the Co-Program Leader for Cancer Control and Survivorship for the Robert H. Lurie Comprehensive Cancer Center.

She is an expert in implementation science, women’s health across the lifespan, minority health, community engagement and health equity. 

She has been recognized with numerous awards for her substantial contribution to excellence in health equity scholarship, women’s health and mentorship, including the Presidential Award in Excellence in Science Mathematics and Engineering Mentorship and a Presidential Leadership Scholar. She is a former member and current consultant to the US Preventive Services Task Force and serves on the NIH Office of Research in Women’s Health Advisory Committee. She is also a member of the National Academy of Medicine’s Board on Population Health and Public Health Practice, the Roundtable on the Promotion of Health Equity and the NAM Leadership Consortium’s Culture Inclusion and Equity Collaborative.

Elizabeth Stier, MD is a professor at Boston University School of Medicine. Dr. Stier is a gynecologist, clinician-researcher, working towards cervical, anal, and vulva cancer prevention especially for people living with HIV. Dr. Stier is chair of the HPV Working Group of the AIDS Malignancy Consortium and a member of the CDC-sponsored HPV disease committee, Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents.

Colleen K. Stockdale, MD, MS is a Clinical Associate Professor of Obstetrics and Gynecology at the University of Iowa.  She is the Director of the Colposcopy and Vulvar Vaginal Disease Clinics, as well as the Obstetrics and Gynecology Clerkship Director.  Dr. Stockdale has served as an ASCCP Board Member since 2010 and has served as faculty for several postgraduate courses and clinical meetings in addition to her service on committees.

Mark H. Stoler, MD is Professor (Emeritus) of Pathology and Clinical Gynecology at the University of Virginia Health System in Charlottesville, V.A. He is a Past President of the American Society for Clinical Pathology (ASCP) and is still active in multiple professional organizations. Dr. Stoler is author or coauthor of over 325 peer-reviewed publications and multiple book chapters. His writings have especially focused on the relationship between human papillomaviruses and cervical carcinogenesis and applications of this knowledge to improving diagnosis and prognosis, including the 2012 American Cancer Society guidelines for cervical cancer screening and the 2012 Lower Anogenital Squamous Terminology (LAST) project.  He is currently actively supporting ongoing prophylactic and therapeutic HPV vaccine trials and multiple HPV-related diagnostic trials as an expert pathologist and consultant.

Alessandro Villa, DDS, PhD, MPH is the Chief of the Sol Silverman Oral Medicine Clinic and Director of Oral Oncology at University of California, San Francisco where he also serves as program director for the Oral Medicine Residency program. Previously, he was faculty at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. He is a founding member of the MA Oral HPV Taskforce. Dr. Villa's research interests are focused primarily on the management of oral potentially malignant disorders and oral complications from cancer treatment. In addition, he is working to reduce the burden of HPV associated oropharyngeal cancers through educational campaigns.

Alan G. Waxman, MD, MPH is Emeritus Professor of Obstetrics and Gynecology at the University of New Mexico (UNM) in Albuquerque, NM.  He completed his medical degree and ob/gyn residency at the University of Colorado and his Masters of Public Health at Emory University.   He joined the faculty of UNM in 2000 after completing a 24 year career with the Indian Health Service. (IHS)

Dr. Waxman’s principle area of interest since 1991 has been cervical cancer screening and prevention.  He has been director of the IHS Colposcopy Courses annually since 1992.  He served on numerous committees of ASCCP including 14 years on the Board of Directors and was the Society’s President 2012-2013.  In 2018 he was awarded ASCCP’s Lifetime Achievement Award. He has lectured nationally and internationally on cervical cancer prevention, human papillomavirus and colposcopy. He has authored numerous articles and book chapters on colposcopy, cervical cancer screening, and related subjects.

Dr. Waxman retired from clinical practice in 2020. He remains actively involved in numerous academic projects related to cervical cancer prevention, and continues to teach colposcopy throughout the U.S. and internationally. 

Kathryn Welch, MD is an Assistant Professor of Obstetrics and Gynecology at the University of Michigan.

She is a Michigan native who earned her undergraduate degree at Michigan State University. Dr. Welch then pursued her medical degree at Wayne State University School of Medicine and completed her residency training in Obstetrics and Gynecology at Wayne State University/Detroit Medical Center. Her practice encompasses general obstetrics and gynecology, with a focus on vulvar diseases.

Outside of work, Dr. Welch enjoys spending time with her husband, daughter and dog. Any spare time is spent relaxing at her family cottage.

Nicolas Wentzensen, MD, PhD received an M.D. in 2000 and a Ph.D. in Applied Tumor Biology in 2007, both from the University of Heidelberg. He conducted research in molecular biology, molecular pathology, and molecular epidemiology at the Department of Surgery and at the Institute of Pathology, University of Heidelberg. He built a research group focusing on cervical cancer biomarker discovery and validation and established a diagnostic laboratory for cervical cancer screening. In 2009 he earned a Master of Science in Epidemiology from the University of Mainz. Dr. Wentzensen joined DCEG as a visiting fellow in 2007, became a tenure-track investigator in 2009, and was awarded scientific tenure by the NIH and appointed senior investigator in 2013. In 2015 he joined the Clinical Genetics Branch as Deputy Chief and head of the newly formed Clinical Epidemiology Unit (CEU) within CGB.

Dr. Wentzensen’s research is focused on clinical epidemiology of gynecological cancers.

Rachel Winer, PhD, MPH is a Professor and Director of Research in the Department of Epidemiology at the University of Washington School of Public Health and an Affiliate Scientific Investigator at Kaiser Permanente Washington Health Research Institute. Her research interests are in the epidemiology and prevention of human papillomavirus (HPV) infections and HPV-related cancers. Dr. Winer earned a MPH in Epidemiology (2002) and PhD in Epidemiology (2005) from the University of Washington.

Amy Wiser, MD (she/her) is a family medicine physician in Portland, Oregon. She completed her undergraduate studies at Penn State University and earned her medical degree at Drexel University College of Medicine. After graduating from family medicine residency training in Pennsylvania, she completed her OB Fellowship through University of Washington in Spokane. Dr Wiser started her career as a full scope family physician in rural Oregon. Over the past decade, she has been faculty at the Oregon Health & Sciences University, with roles of Assistant Residency Director in the family medicine program as well as Didactic Curriculum Co-Director in the OHSU School of Medicine in Portland, Oregon.

Dr. Wiser’s clinical interests include gynecological health, maternity care and gender affirming health care. Dr Wiser is on the Board of Directors of the ASCCP and active faculty. She has traveled internationally teaching with ASCCP, served as Director of the Comprehensive Colposcopy Course and has contributed to the 2019 ASCCP Risk-Based Management Consensus Guidelines.